Accessibility Menu

Canopy Growth(FRA) 11L1

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
N/A

Canopy Growth Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$182.18

Net Income (TTM)

-$145.08

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

11L1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Industry

Pharmaceuticals

Employees

1,128

CEO

Luc Mongeau

11L1 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Canopy Growth Performance Analysis

Canopy Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 242,172,856-30.9%
20242024-03-31USD 203,181,143-16.1%
20252025-03-31USD 180,140,299-11.3%
20262026-03-31USD 177,713,993-1.3%
Canopy Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -51.37844.3%
20242024-03-31USD -6.01-88.3%
20252025-03-31USD -3.17-47.3%
20262026-03-31USD -0.55-82.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$50.42

+1.1%

Gross Profit

$10.20

+1.3%

Gross Margin

20.23%

+1.2%

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$0.32

N/A

Employees

1,128

N/A

Net Income

-$9.06

+0.3%

EBITDA

-$4.69

+0.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$378.50

+33.5%

Total Debt

$170.97

+0.8%

Accounts Receivable

$20.06

+0.7%

Inventory

$66.25

+1.1%

Long Term Debt

$144.42

+0.7%

Short Term Debt

$26.55

+2.2%

Return on Assets

-23.30%

+0.5%

Return on Invested Capital

-70.70%

+1.0%

Free Cash Flow

-$16.00

+2.2%

Operating Cash Flow

-$15.54

+2.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 11L1

What is the current price of Canopy Growth?

Canopy Growth is trading at N/A per share.

What is the 52-week range for Canopy Growth?

Over the past 52 weeks, Canopy Growth has traded between N/A and N/A.

How much debt does Canopy Growth have?

As of the most recent reporting period, Canopy Growth reported total debt of $170.97M.

How much cash does Canopy Growth have on hand?

Canopy Growth reported $207.53M in cash and cash equivalents in its most recent financial results.

What is Canopy Growth’s dividend yield?

Canopy Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.